Bleeding management in patients with new oral anticoagulants

New oral anticoagulants (NOACs) have been developed in recent years and are increasingly used in clinical practice. Dabigatran is a direct thrombin (factor II) inhibitor while rivaroxaban, apixaban and edoxaban are direct inhibitors of factor Xa. The European Medicines Agency (EMA) currently approve...

Full description

Saved in:
Bibliographic Details
Published inMinerva anestesiologica Vol. 82; no. 8; p. 884
Main Authors Vargas, Maria, Marra, Annachiara, Perrone, Antonietta, Servillo, Giuseppe
Format Journal Article
LanguageEnglish
Published Italy 01.08.2016
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first